Profile
Melissa McCracken is currently an Independent Director at Tyra Biosciences, Inc. since 2021.
Dr. McCracken is a Director at Alpha-9 Oncology, Inc. and Ambagon Therapeutics, Inc. Dr. McCracken is a Partner at Nextech Invest AG since 2019 and a Partner at Nextech Ventures (US) LLC since 2021.
Formerly, Dr. McCracken was a Director at ImaginAb, Inc. Dr. McCracken earned a doctorate from the University of California, Los Angeles and completed undergraduate studies at the University of California, Davis.
Melissa McCracken active positions
| Companies | Position | Start |
|---|---|---|
| TYRA BIOSCIENCES, INC. | Director/Board Member | 01/03/2021 |
Ambagon Therapeutics, Inc.
Ambagon Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Develops protein medicines | Director/Board Member | - |
Alpha-9 Oncology, Inc.
Alpha-9 Oncology, Inc. BiotechnologyHealth Technology Engages in research clinical stage radiopharmaceutical and drug design for cancer treatment | Director/Board Member | - |
Nextech Ventures Us LLC
Nextech Ventures Us LLC Investment ManagersFinance Functions as an alternative investment manager | Private Equity Investor | 01/11/2021 |
Nextech Invest AG
Nextech Invest AG Investment ManagersFinance Nextech invests in companies located in the United States and Europe. The firm focuses on the bio technology sector. It provides financing for early-stage capital requirements. | Private Equity Investor | 01/01/2019 |
Former positions of Melissa McCracken
| Companies | Position | End |
|---|---|---|
ImaginAb, Inc.
ImaginAb, Inc. Medical SpecialtiesHealth Technology Develops radiopharmaceutical and imaging agent products | Director/Board Member | - |
Training of Melissa McCracken
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Nextech Invest AG
Nextech Invest AG Investment ManagersFinance Nextech invests in companies located in the United States and Europe. The firm focuses on the bio technology sector. It provides financing for early-stage capital requirements. | Finance |
University of California, Los Angeles
University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Davis
University of California, Davis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ImaginAb, Inc.
ImaginAb, Inc. Medical SpecialtiesHealth Technology Develops radiopharmaceutical and imaging agent products | Health Technology |
Tyra Biosciences, Inc.
Tyra Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops cancer treatment drug therapies | Health Technology |
Nextech Ventures Us LLC
Nextech Ventures Us LLC Investment ManagersFinance Functions as an alternative investment manager | Finance |
Ambagon Therapeutics, Inc.
Ambagon Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Develops protein medicines | Health Technology |
Alpha-9 Oncology, Inc.
Alpha-9 Oncology, Inc. BiotechnologyHealth Technology Engages in research clinical stage radiopharmaceutical and drug design for cancer treatment | Health Technology |
- Stock Market
- Insiders
- Melissa McCracken
















